Egan M A, Kuroda M J, Voss G, Schmitz J E, Charini W A, Lord C I, Forman M A, Letvin N L
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
J Virol. 1999 Jul;73(7):5466-72. doi: 10.1128/JVI.73.7.5466-5472.1999.
To evaluate the impact of the diversity of antigen recognition by T lymphocytes on disease pathogenesis, we must be able to identify and analyze simultaneously cytotoxic T-lymphocyte (CTL) responses specific for multiple viral epitopes. Many of the studies of the role of CD8(+) CTLs in AIDS pathogenesis have been done with simian immunodeficiency virus (SIV)- and simian-human immunodeficiency virus (SHIV)-infected rhesus monkeys. These studies have frequently made use of the well-defined SIV Gag CTL epitope p11C,C-M presented to CTL by the HLA-A homologue molecule Mamu-A01. In the present study we identified and fine mapped two novel Mamu-A01-restricted CTL epitopes: the SIVmac Pol-derived epitope p68A (STPPLVRLV) and the human immunodeficiency virus type 1 (HIV-1) Env-derived p41A epitope (YAPPISGQI). The frequency of CD8(+) CTLs specific for the p11C,C-M, p68A, and p41A epitopes was quantitated in the same animals with a panel of tetrameric Mamu-A01/peptide/beta2m complexes. All SHIV-infected Mamu-A01(+) rhesus monkeys tested had a high frequency of SIVmac Gag-specific CTLs to the p11C,C-M epitope. In contrast, only a fraction of the monkeys tested had detectable CTLs specific for the SIVmac Pol p68A and HIV-1 Env p41A epitopes, and these responses were detected at very low frequencies. Thus, the p11C,C-M-specific CD8(+) CTL response is dominant and the p41A- and p68A-specific CD8(+) CTL responses are nondominant. These results indicate that CD8(+) CTL responses to dominant CTL epitopes can be readily quantitated with the tetramer technology; however, CD8(+) CTL responses to nondominant epitopes, due to the low frequency of these epitope-specific cells, may be difficult to detect and quantitate by this approach.
为了评估T淋巴细胞对抗原识别的多样性对疾病发病机制的影响,我们必须能够同时鉴定和分析针对多种病毒表位的细胞毒性T淋巴细胞(CTL)反应。许多关于CD8(+) CTL在艾滋病发病机制中作用的研究是在感染了猿猴免疫缺陷病毒(SIV)和猿猴-人类免疫缺陷病毒(SHIV)的恒河猴中进行的。这些研究经常利用由HLA-A同源分子Mamu-A01呈递给CTL的明确的SIV Gag CTL表位p11C,C-M。在本研究中,我们鉴定并精细定位了两个新的Mamu-A01限制性CTL表位:源自SIVmac Pol的表位p68A(STPPLVRLV)和源自人类免疫缺陷病毒1型(HIV-1)Env的p41A表位(YAPPISGQI)。使用一组四聚体Mamu-A01/肽/beta2m复合物在相同动物中定量了针对p11C,C-M、p68A和p41A表位的CD8(+) CTL的频率。所有测试的感染SHIV的Mamu-AO1(+)恒河猴对p11C,C-M表位都有高频的SIVmac Gag特异性CTL。相比之下,只有一部分测试的猴子有可检测到的针对SIVmac Pol p68A和HIV-1 Env p41A表位的CTL,并且这些反应的检测频率非常低。因此,p11C,C-M特异性CD8(+) CTL反应是主导性的,而p41A和p68A特异性CD8(+) CTL反应是非主导性的。这些结果表明,使用四聚体技术可以很容易地定量针对主导CTL表位的CD8(+) CTL反应;然而,由于这些表位特异性细胞的频率较低,针对非主导表位的CD8(+) CTL反应可能难以通过这种方法检测和定量。